Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Aaa, abandon, adult, analyzing, annum, Archimica, backed, benchmark, benchmarking, calendar, capped, Chairman, chose, Clariant, contemplated, coupled, coupon, customary, decree, diminished, disoproxil, dissolved, downgraded, enjoin, eventual, exit, faculty, forward, FSPNo, fumerate, GSK, headcount, hierarchy, Homeowner, HSR, inactive, indeterminate, injunction, Lastly, load, MA, matrix, mortgage, multiproject, nonappealable, null, orderly, placebo, plasma, prepayment, randomized, recovery, rejected, rental, restrain, rollforward, scientist, SECat, shelf, specialty, spread, Stability, sublease, subleased, sue, supplier, swap, tenofovir, tiered, treatable, twelve, unchanged, undergoing, underwritten, undiscounted, Universite, unobservable, unspecified, Viread, vivo, void, waiver, warranted, watch, worsening
Removed:
abuse, affiliated, allege, alleged, allotment, anticipation, APB, approximate, arbitration, asserting, awarded, bar, capitalize, charged, Chiron, commencing, competitor, computer, contractually, converted, convict, counsel, Cutler, declaratory, decompensated, deducting, default, defense, derive, devoted, disagree, dismissed, District, diversity, Dorr, encompassing, exclusion, exclusivity, false, FAS, forma, fraudulent, FSP, generically, genotype, GLOBE, Hale, higher, IIb, IIIb, illegal, induce, influence, inherited, integrity, interim, interpret, investigation, knowingly, label, light, list, mediation, medically, Medicare, minimal, Nationale, nonexclusively, occupancy, opportunity, overcome, Pickering, placement, presenting, professor, prohibited, prosecutorial, prospective, punishable, purportedly, reached, reclassified, referral, reform, regional, remuneration, repeated, reset, resigning, resolve, restrictive, rule, SARL, satisfied, scrutiny, short, Simultaneously, Sommadossi, sooner, spending, terminating, unnecessary, Unresolved, violating, violation, vivopharmacokinetic, vivopharmacology, waive, widely, willingly, Wilmer
Filing tables
Filing exhibits
- 10-K Annual report
- 10.28 EX-10.28 License Agreement, Dated February 4, 2009
- 10.35 EX-10.35 Amendment Agreement, Dated February 4, 2009
- 10.46 EX-10.46 Agreement, Dated December 3, 2008
- 10.55 EX-10.55 Amendment No. 1 to Employment Agreement, Dated December 23, 2008
- 21.1 EX-21.1 Subsidiaries of the Company
- 23.1 EX-23.1 Consent of Pricewaterhousecoopers LLP
- 31.1 EX-31.1 CEO Cert Section 302
- 31.2 EX-31.2 CFO Cert Section 302
- 32.1 EX-32.1 CEO Cert Section 906
- 32.2 EX-32.2 CFO Cert Section 906
Related press release
IDIX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-118341, 333-128882 and 333-143620) and Form S-3 (File Nos. 333-127710, 333-129213 and 333-153471) of Idenix Pharmaceuticals, Inc. of our report dated February 27, 2009 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 4, 2009
Boston, Massachusetts
March 4, 2009